{
    "title": "AbbVie trims forecast for Humira sales drop on favorable coverage",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12344581/AbbVie-raises-profit-forecast-Humira-stays-strong-new-drugs-impress.html",
    "date": "2023-07-27",
    "keywords": [
        "humira",
        "drug",
        "market",
        "abbvie",
        "quarter",
        "analyst",
        "skyrizi",
        "leo",
        "wingrove",
        "insurance",
        "coverage",
        "drugmaker",
        "profit",
        "forecast",
        "share",
        "call",
        "pbms",
        "month",
        "company",
        "july",
        "thursday",
        "view",
        "flagship",
        "competition",
        "fall",
        "demand",
        "trajectory",
        "entry",
        "pharmacy",
        "benefit",
        "placement",
        "reimbursement",
        "officer",
        "conference",
        "access",
        "caremark",
        "cigna",
        "unitedhealth",
        "negotiate",
        "behalf",
        "health",
        "insurer",
        "revenue",
        "percentage",
        "street",
        "amgen",
        "amjevita",
        "lone",
        "biosimilar",
        "launch",
        "parity",
        "erosion",
        "capital",
        "price",
        "list",
        "discount",
        "immunology",
        "rinvoq",
        "drop",
        "investor",
        "botox",
        "use",
        "executive",
        "growth",
        "estimate",
        "reporting",
        "bengaluru",
        "york",
        "editing",
        "sriraj",
        "kalluvila",
        "jonathan",
        "oatis",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}